Fauci investigation news, gain-of-function funding controversy, perjury allegations against Fauci

BREAKING: @DNIGabbard CONFIRMS Fauci Under Investigation for Perjury — Wuhan Lab Funding EXPOSED.
In a jaw-dropping turn, DNI Tulsi Gabbard just confirmed that Anthony Fauci is officially under investigation for PERJURY and his role in secretly funding gain-of-function… pic.twitter.com/1wi5drxdmI

• Check out these discounted items on Amazon

— Project Constitution (@ProjectConstitu) August 15, 2025

BREAKING: @DNIGabbard CONFIRMS Fauci Under Investigation for Perjury

In a surprising announcement, Tulsi Gabbard, the Director of National Intelligence (DNI), has confirmed that Anthony Fauci is under investigation for perjury. This revelation has sent shockwaves through the political landscape, especially considering the ongoing debates surrounding the origins of COVID-19 and the funding of the Wuhan Institute of Virology.

Fauci’s Role in Wuhan Lab Funding EXPOSED

The investigation centers around Fauci’s alleged involvement in secretly funding gain-of-function research at the Wuhan lab. Gain-of-function research has been a controversial topic, with critics arguing that it poses significant risks by enhancing the pathogenicity of viruses. Gabbard’s claims have reignited discussions about transparency and accountability in the federal government, particularly concerning public health policies.

Gabbard’s confirmation comes at a time when many are seeking clarity on the origins of the coronavirus. With various theories circulating, this investigation could provide vital insights into how the pandemic began and the role that U.S. funding may have played.

Implications of the Investigation

The implications of Fauci’s investigation are vast. If he is found guilty of perjury, it could lead to significant repercussions for his career and the trust placed in health officials during a global health crisis. Public confidence in government institutions is already fragile, and this investigation may further erode that trust.

As this story develops, many are left wondering what the outcome will mean for the future of public health policy in the United States. Will this lead to more stringent regulations on research funding? Or could it spark a broader inquiry into government accountability?

Stay tuned as more details emerge.